This page will no longer be active or monitored. For updates on our work, please follow Genmab at: https://bit.ly/3Kf80df. ProfoundBio is now part of Genmab. As part of Genmab, we are looking forward to continuing our work of developing novel antibody-based therapeutics for patients with cancer.
| Website | http://www.genmab.com |
| Revenue | $2.9 billion |
| Employees | 9 (5 on RocketReach) |
| Industry | Biotechnology Research |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Genmab +40 more (view full list) |
Looking for a particular ProfoundBio employee's phone or email?
ProfoundBio Questions
The ProfoundBio annual revenue was $2.9 billion in 2026.
Erin Lavelle is the Chief Operating Officer and Chief Financial Officer of ProfoundBio.
5 people are employed at ProfoundBio.
ProfoundBio is based in Woodinville, Washington.
Top ProfoundBio Employees
Related Companies
